Pfizer said Tuesday it expects to apply for emergency use authorization to administer its COVID-19 vaccine to children ages 2 to 11 in September.
The company made the comments in an earnings call on Tuesday and also said it plans to file for full approval from the Food and Drug Administration for the use of its vaccine in 16- to 85-year-olds, beyond the emergency use authorization granted in December. The approval would be a milestone that could help alleviate some Americans’ concerns and vaccine hesitancy.
- Sweden’s Lund University researcher faces prosecution for study that showed most rapes are committed by immigrants
- Human beings aren’t clownfish
- Campus Crusade for Christ Goes All In On Critical Race Theory
- What the ever living? Report–Governor Kristi Noem is having an extramarital affair with adviser Corey Lewandowski
- Inside the January 6th Setup– Who is Ray Epps?
- Michigan High School Student Sues School for Suspending Him for Talking About Christian Beliefs in Private